EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer

A small subset of patients with nonsmall cell lung cancer (NSCLC) harbors mutations in the epidermal growth factor receptor (EGFR) that predict unique sensitivity to EGFR tyrosine kinase inhibitors (TKIs). The characteristics and behavior of brain metastases (BMs) in these patients have not been wel...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Eichler, April F., Kahle, Kristopher T., Wang, Daphne L., Joshi, Victoria A., Willers, Henning, Engelman, Jeffrey A., Lynch, Thomas J., Sequist, Lecia V.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2010
Sujets:
Clinical Investigations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3098020/
https://ncbi.nlm.nih.gov/pubmed/20627894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq076
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires